Cargando…

Adverse effects of COVID-19 pandemic on a multicenter randomized controlled trial

OBJECTIVE: Describe the effects of the COVID-19 pandemic on subject enrollment in a multicenter randomized controlled trial. STUDY DESIGN: We assessed the number of eligible infants approached and consented for enrollment over five separate epochs including baseline, peak pandemic, and gradual but i...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu Jawdeh, Elie G., Hunt, Carl E., Eichenwald, Eric, Corwin, Michael J., McEntire, Betty, Heeren, Timothy, Crowell, Lisa M., Ikponmwonba, Christine, Saroufim, Ariana, Kerr, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798371/
https://www.ncbi.nlm.nih.gov/pubmed/36581761
http://dx.doi.org/10.1038/s41372-022-01592-2
_version_ 1784860896007290880
author Abu Jawdeh, Elie G.
Hunt, Carl E.
Eichenwald, Eric
Corwin, Michael J.
McEntire, Betty
Heeren, Timothy
Crowell, Lisa M.
Ikponmwonba, Christine
Saroufim, Ariana
Kerr, Stephen
author_facet Abu Jawdeh, Elie G.
Hunt, Carl E.
Eichenwald, Eric
Corwin, Michael J.
McEntire, Betty
Heeren, Timothy
Crowell, Lisa M.
Ikponmwonba, Christine
Saroufim, Ariana
Kerr, Stephen
author_sort Abu Jawdeh, Elie G.
collection PubMed
description OBJECTIVE: Describe the effects of the COVID-19 pandemic on subject enrollment in a multicenter randomized controlled trial. STUDY DESIGN: We assessed the number of eligible infants approached and consented for enrollment over five separate epochs including baseline, peak pandemic, and gradual but incomplete recovery. RESULT: The pandemic had a major effect on ability to approach parents for consent. Parents approached dropped from 95.4% baseline to 13.1% in the peak pandemic epoch and has not recovered to baseline even in the just-completed post-pandemic epoch (84.9%). Despite the decrease in subjects approached, there was no significant change in the overall consent rate for the study CONCLUSION: The pandemic has significantly limited ability to approach parents of eligible infants for consent, with only partial recovery. Opportunities for interactions of investigators and study coordinators with parents continue to present challenges limiting full recovery.
format Online
Article
Text
id pubmed-9798371
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-97983712022-12-29 Adverse effects of COVID-19 pandemic on a multicenter randomized controlled trial Abu Jawdeh, Elie G. Hunt, Carl E. Eichenwald, Eric Corwin, Michael J. McEntire, Betty Heeren, Timothy Crowell, Lisa M. Ikponmwonba, Christine Saroufim, Ariana Kerr, Stephen J Perinatol Article OBJECTIVE: Describe the effects of the COVID-19 pandemic on subject enrollment in a multicenter randomized controlled trial. STUDY DESIGN: We assessed the number of eligible infants approached and consented for enrollment over five separate epochs including baseline, peak pandemic, and gradual but incomplete recovery. RESULT: The pandemic had a major effect on ability to approach parents for consent. Parents approached dropped from 95.4% baseline to 13.1% in the peak pandemic epoch and has not recovered to baseline even in the just-completed post-pandemic epoch (84.9%). Despite the decrease in subjects approached, there was no significant change in the overall consent rate for the study CONCLUSION: The pandemic has significantly limited ability to approach parents of eligible infants for consent, with only partial recovery. Opportunities for interactions of investigators and study coordinators with parents continue to present challenges limiting full recovery. Nature Publishing Group US 2022-12-29 2023 /pmc/articles/PMC9798371/ /pubmed/36581761 http://dx.doi.org/10.1038/s41372-022-01592-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Abu Jawdeh, Elie G.
Hunt, Carl E.
Eichenwald, Eric
Corwin, Michael J.
McEntire, Betty
Heeren, Timothy
Crowell, Lisa M.
Ikponmwonba, Christine
Saroufim, Ariana
Kerr, Stephen
Adverse effects of COVID-19 pandemic on a multicenter randomized controlled trial
title Adverse effects of COVID-19 pandemic on a multicenter randomized controlled trial
title_full Adverse effects of COVID-19 pandemic on a multicenter randomized controlled trial
title_fullStr Adverse effects of COVID-19 pandemic on a multicenter randomized controlled trial
title_full_unstemmed Adverse effects of COVID-19 pandemic on a multicenter randomized controlled trial
title_short Adverse effects of COVID-19 pandemic on a multicenter randomized controlled trial
title_sort adverse effects of covid-19 pandemic on a multicenter randomized controlled trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798371/
https://www.ncbi.nlm.nih.gov/pubmed/36581761
http://dx.doi.org/10.1038/s41372-022-01592-2
work_keys_str_mv AT abujawdehelieg adverseeffectsofcovid19pandemiconamulticenterrandomizedcontrolledtrial
AT huntcarle adverseeffectsofcovid19pandemiconamulticenterrandomizedcontrolledtrial
AT eichenwalderic adverseeffectsofcovid19pandemiconamulticenterrandomizedcontrolledtrial
AT corwinmichaelj adverseeffectsofcovid19pandemiconamulticenterrandomizedcontrolledtrial
AT mcentirebetty adverseeffectsofcovid19pandemiconamulticenterrandomizedcontrolledtrial
AT heerentimothy adverseeffectsofcovid19pandemiconamulticenterrandomizedcontrolledtrial
AT crowelllisam adverseeffectsofcovid19pandemiconamulticenterrandomizedcontrolledtrial
AT ikponmwonbachristine adverseeffectsofcovid19pandemiconamulticenterrandomizedcontrolledtrial
AT saroufimariana adverseeffectsofcovid19pandemiconamulticenterrandomizedcontrolledtrial
AT kerrstephen adverseeffectsofcovid19pandemiconamulticenterrandomizedcontrolledtrial
AT adverseeffectsofcovid19pandemiconamulticenterrandomizedcontrolledtrial